[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349043-105":59,"doc-detail-349043-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","key-hub-genes-identification-and-therapeutic-target-prediction-via-multi-validation-for-the-senescence-inflammation-axis-in-prostate-cancer","Key hub genes identification and therapeutic target prediction via multi-validation for the senescence-inflammation axis in prostate cancer","","Cellular senescence reshapes the tumor microenvironment through SASP, while immune-driven inflammation promotes carcinogenesis via DNA damage and immune remodeling. This study investigates how the senescence–inflammation gene network functions in prostate cancer progression, using GEO gene-expression profiles, differential gene screening, and bioinformatics pathway analyses (GO/KEGG). Immune infiltration and single-cell data characterize related immune processes, while drug-target interaction prediction identifies candidate therapeutic agents. Four core genes are identified and validated as TXN, TOP2A, ANXA2, and HSP90B1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/key-hub-genes-identification-and-therapeutic-target-prediction-via-multi-validation-for-the-senescence-inflammation-axis-in-prostate-cancer/349043/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/key-hub-genes-identification-and-therapeutic-target-prediction-via-multi-validation-for-the-senescence-inflammation-axis-in-prostate-cancer/349043.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological focus of this study in prostate cancer?","Question",{"text":112,"@type":113},"Cellular senescence remodels the microenvironment via SASP, and immune inflammation promotes carcinogenesis through DNA damage and immune remodeling, forming a vicious cycle relevant to prostate cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were key hub genes identified and verified?",{"text":117,"@type":113},"Differentially expressed genes were screened from GEO gene-expression profiles using bioinformatics, verified by experiments, and analyzed with GO/KEGG enrichment. Hub genes were then derived via core gene/target analyses and supported by single-cell immune-cell expression findings.",{"name":119,"@type":110,"acceptedAnswer":120},"Which core genes and therapeutic agents were highlighted in the findings?",{"text":121,"@type":113},"Four core genes were identified and validated: TXN, TOP2A, ANXA2, and HSP90B1. Predicted potential therapeutic agents include resveratrol and regorafenib, along with additional candidates Miconazole, Fostamatinib, and Quercetin.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349043,1790844997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nKey hub genes identification and therapeutic target prediction via multi-validation for thesenescence-inflammation axis in prostate cancer  \nYing Wang1,6, Qin Liu2,6, Mei Yi3, Yan Liu4, Ji’ang’shu He5 & Han Chao Zhang5􀀍  \nCellular senescence remodels the microenvironment via SASP, and immune inflammation promotes carcinogenesis through DNA damage and immune remodeling; the“senescence-inflammation”  \nvicious cycle formed by these two processes is a core driver of cancer development and progression, yet its mechanism in prostate cancer progression remains unclear. The regulatory mechanisms of“senescence-inflammation” related genes in prostate cancer were revealed, targeted drugs were predicted, and new insights were provided for the clinical treatment of prostate cancer. In this study, gene expression profile data of prostate cancer were obtained from the Gene Expression Omnibus (GEO). Differentially expressed genes were screened out through bioinformatics analysis and verified by experiments; GO and KEGG analyses were used to explore the prostate cancer-specific biological processes and signaling pathways involved, immune infiltration characteristics were revealed by combining immune infiltration tools with single-cell technology, and finally, drugs with therapeutic potential were predicted through core gene target analysis. Prostate cancer-related differentially expressed genes were found to number 203. Notable hub genes included ACTB, RPLP0, TOP2A, TXN, HSP90B1, TAGLN, RPSA, and ANXA2. According to enrichment analysis, apoptosis, cellular senescence, inflammation, and the initiation of immunological responses are the main factors contributing to the development of bladder cancer. The immunological processes of prostate cancer are significantly influenced by memory B cells, CD8 T cells, follicular helper T cells, M1 macrophages, monocytes, and NK cells, as confirmed by immune infiltration and single-cell data. Furthermore, hub genes were found to be significantly expressed in a variety of immune cells by single-cell studies; monocytes and macrophages in particular exhibited high levels ofACTB, RPLP0, RPSA, and ANXA2 . We next used Western blotting, PCR, and immunohistochemistry to evaluate these genes’ expression in clinical samples. Lastly, Miconazole, Fostamatinib, Quercetin, Resveratrol, and Regorafenib were shown to be possible important drugs or ingredients for the treatment of prostate cancer by our drugtarget interaction prediction analysis. We clarified the mechanism by which immune-inflammatory and aging-related genes contribute to the pathogenesis of prostate cancer. We identified and validated four core genes, namely TXN, TOP2A, ANXA2, and HSP90B1, and predicted potential therapeutic agents, specifically resveratrol and regorafenib. These findings provide a theoretical basis for research on the molecular mechanisms of prostate cancer and its clinical treatment.  \nKeywords Prostate cancer, Inflammation, Drug-target interaction prediction, Biomarkers, Immunity  \n1Department of Emergency, The Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu, Sichuan, China. 2Department of Human Anatomy, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China. 3Department of Nephrology and Rheumatology, The Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu, Sichuan, China. 4Hospital-Acquired Infection Control Department, The Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu, Sichuan, China. 5Department of Urology, The Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu, Sichuan, China.  \n6These authors contributed equally: Ying Wang and Qin Liu. 􀀍 email: [zhanghanchao@cdu.edu.cn](zhanghanchao@cdu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nMen in industrialized nations a","cbCaieBBhLvbXZ4i","https://ap.wps.com/l/cbCaieBBhLvbXZ4i","pdf",12519879,"English","# Introduction\n## Prostate cancer risk factors and biomarkers\n## Role of inflammation, immunity, and cellular senescence\n# Methods and Analyses\n## Differential gene screening and validation\n## GO/KEGG pathway enrichment\n## Immune infiltration and single-cell analysis\n## Drug-target interaction prediction\n# Results\n## Differentially expressed genes and hub genes\n## Core genes and immune cell associations\n## Experimental validation in clinical samples\n## Predicted therapeutic agents\n# Conclusion","[{\"question\":\"What is the main biological focus of this study in prostate cancer?\",\"answer\":\"Cellular senescence remodels the microenvironment via SASP, and immune inflammation promotes carcinogenesis through DNA damage and immune remodeling, forming a vicious cycle relevant to prostate cancer progression.\"},{\"question\":\"How were key hub genes identified and verified?\",\"answer\":\"Differentially expressed genes were screened from GEO gene-expression profiles using bioinformatics, verified by experiments, and analyzed with GO/KEGG enrichment. Hub genes were then derived via core gene/target analyses and supported by single-cell immune-cell expression findings.\"},{\"question\":\"Which core genes and therapeutic agents were highlighted in the findings?\",\"answer\":\"Four core genes were identified and validated: TXN, TOP2A, ANXA2, and HSP90B1. Predicted potential therapeutic agents include resveratrol and regorafenib, along with additional candidates Miconazole, Fostamatinib, and Quercetin.\"}]","Key hub genes identification and therapeutic target prediction via multi-validation for the senescence-inflammation axis in prostate cancer | PDF",1790081361,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b269b6204cb421245b4c557c7bb77570.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b05e49157cb796fc4035e8ffcb4542c.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d31e85a68666819872e8d6177220fd8.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf139e144ac8a133d134f87b1777da7c.webp",980,1287]